Launch of the Manchester Fungal Infection Group (MFIG - Sept 2015)

0 comment(s)

Manchester leads the world in the fight against deadly fungal infections with the opening of new Centre - a powerful partnership between research, doctors and industry to help 300 million people across the globe.

The latest scientific research against the potentially deadlyAspergillus fungus was displayed today (9 September) asthe Manchester Fungal Infection Group (MFIG) was officially opened by Professor Sir Robert Boyd.

GAFFI president tours China making the case for improved fungal diagnostics

0 comment(s)

Early in August, Professor Denning visited Lanzhou, Hangzhou, Shanghai and Guangzhou meeting clinicians, visiting laboratories and educating physicians about the large burden of fungal disease and the opportunity for improved diagnostics. He cited one example from China of the likely number of deaths from invasive aspergillosis in COPD patients. Of the estimated 32.8 million people with COPD, nearly 12 million are admitted to hospital each year. A study in nearly 300 admissions in Guangzhou showed 3.9% to have invasive aspergillosis, and 43% died.

GAFFI calls for a shake up in the way the world views fungal diseases

0 comment(s)

Today, May 5th at the ISHAM conference GAFFI has launched the project ‘95-95 by 2025’ at Melbourne in Australia, calling on all national governments and public health agencies to reduce the toll of death and blindness from fungal diseases. 95-95 means 95 percent of patients with life or sight-threatening fungal disease are diagnosed and 95 percent treated. Currently the figures are at best 50 percent and, at worst, as low as one in three.

GAFFI states that: